Rare diseases
Investigational molecules
Locations
382 conditions with trials, the busiest first
846 trials across Europe, recruiting first
Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
BulgariaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
AustriaEvaluation of topical clascoterone versus drug combination for skin vasoconstriction in healthy volunteers
GermanyComparing Two Oral Doses of macitentan (10 mg vs 75 mg) in Healthy Participants for Pulmonary Arterial Hypertension
FranceFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
FranceA study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.
GermanyA study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure
BulgariaEvaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers
CzechiaBioequivalence Study of Ticagrelor 90 mg Capsules (PG402) vs Tablets in Healthy Volunteers for Prevention of Acute Coronary Syndrome
PolandA study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis
BelgiumBioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms
GermanyThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
